CORDIS gateway to FP7

In anticipation of the final approval of the Seventh Framework Programme (FP7) by the European Council, CORDIS, the Community Research and Development Information Service, has launched a new FP7 service. The new web service provides the latest state of play as the EU's new research and development (R&D) programme moves into its implementation phase. It will then develop into a fully-fledged support service for all potential participants and interested parties.

The service, which replaces the current 'Towards FP7' pages, provides detailed information on the specific programmes and themes, participation rules and official documents related to FP7. It also contains all the latest developments, announcements and events relevant to FP7.

Adopted work programmes and calls for project proposals will be published on this service as soon as they are available.

The new pages allow users to learn about FP7 in general and, in particular, its specific programmes and their themes, as well as the activities related to Euratom and the Joint Research Centre (JRC). There is also a set of fact sheets in 21 languages, providing general information about the new Framework Programme.

In addition to background information, the new service also includes an FP7 Newsroom, where the most important latest developments relevant to FP7 are highlighted and explained.

For potential participants, there is a guidance section explaining the rules of participation in FP7, including eligibility criteria, explanations of the most important procedures, and a summary of the different types of participation that are available.

The new FP7 service also provides access to sources of support for participants, ranging from the newly-appointed National Contact Points (NCPs) in each of the EU Member States and associated countries, to a network of liaison officers.

A specific search mechanism for relevant documents in the FP7 library completes the new service, which will continue to develop as the central gateway for all FP7-related information on CORDIS; with a partner search facility to help build FP7 project teams planned for the near future.

For further information, please visit:
http://cordis.europa.eu/fp7

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...